National Pension Service bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 235,238 shares of the company’s stock, valued at approximately $39,153,000.
Several other large investors have also recently bought and sold shares of ALAB. Vanguard Group Inc. raised its stake in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after purchasing an additional 1,693,918 shares during the last quarter. Amundi raised its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC acquired a new position in Astera Labs during the 3rd quarter valued at $209,599,000. BNP Paribas Financial Markets raised its stake in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Astera Labs during the 3rd quarter valued at $131,539,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Astera Labs Stock Performance
Shares of ALAB stock opened at $343.05 on Monday. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $354.53. The stock has a market cap of $58.80 billion, a price-to-earnings ratio of 231.79, a P/E/G ratio of 4.54 and a beta of 3.94. The firm has a fifty day moving average of $190.82 and a 200-day moving average of $165.06.
Insider Transactions at Astera Labs
In other news, CEO Jitendra Mohan sold 28,737 shares of the company’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total value of $7,173,329.94. Following the sale, the chief executive officer owned 3,789,232 shares of the company’s stock, valued at approximately $945,868,091.84. This represents a 0.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel directly owned 103,343 shares in the company, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 2,306,257 shares of company stock valued at $473,685,936. 10.40% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on ALAB. TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Jefferies Financial Group restated a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Susquehanna increased their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Finally, Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $233.75.
Check Out Our Latest Stock Analysis on ALAB
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
